Buying $100 In ABBV: If an investor had bought $100 of ABBV stock 5 years ago, it would be worth $212.70 today based on a price of $204.94 for ABBV at the time of writing.

A recent FDA letter to makers and distributors of a decades-old thyroid medication has stoked outrage among a subset of ...

The U.S. Food and Drug Administration has approved Tonix Pharmaceuticals' drug to manage pain related to a type of chronic ...

Shares of UnitedHealth Group (NYSE:UNH) soared on Friday with news that several prominent investors had purchased shares of the health insurance company. A well-known member of Congress is also buying ...

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3 clinical study ...

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3 clinical study ...

Avalo Therapeutics (NASDAQ:AVTX) stock rises as Cantor Fitzgerald launches coverage with an Overweight rating, highlighting its lead asset, AVTX-009. Read more here.

Tonix Pharmaceuticals was founded in 2010 to develop and bring to market a drug for fibromyalgia. | Tonix Pharmaceuticals was ...

Trump’s push for price cuts and tariffs weighs on ‘obesity franchises’, which have missed out on equity market’s rise ...

This chart summarizes the case name, presiding judge, drug, and patents-at-issue in all federal district court cases that are ...

Ustekinumab and vedolizumab both demonstrated safety and efficacy in treating Crohn’s disease of the pouch, according to ...

AbbVie unveiled a $195 million investment to expand active pharmaceutical ingredient manufacturing in the U.S. Bloomberg reported that BlinkRx, a company that has Donald Trump Jr. on its board, just ...